EBS News and Press, Emergent Biosolutions Inc. From 08/08/23

Actions bring sharpened focus on MCM and NARCAN ® Nasal Spray products Expected to improve operational efficiencies and deliver annual cost savings over $100 million annually GAITHERSBURG, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced ...

2023-08-01 08:26:13 ET Stock futures dipped early Tuesday as the corporate earnings season kicks into high gear. Here are some of Tuesday's biggest stock movers in premarket trading: Biggest stock gainers For further details see: Biggest stock movers today: Arista Netwo...

GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) withi...

GAITHERSBURG, Md., July 25, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 8, 2023, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2023, recent business developments, revenue guidance for the third...

2023-07-21 08:14:47 ET BioNexus Gene Lab Corp  ( BGLC ) +56% . Digital World Acquisition  ( DWAC ) +23% jumps 29% amid settlement with SEC. Guardforce AI ( GFAI ) +16% . Bragg Gaming Group  ( BRAG ) +13% . Emergent BioSolu...

2023-07-21 05:52:56 ET U.S. stock futures inched higher during Friday's early hours of trade after the Dow celebrated its longest rise since 2017, with a ninth day of gains. Nasdaq futures are also recovering after their worst session since early March . Here are some of Friday's bi...

2023-07-21 05:42:00 ET Summary Today, we take a look at a life sciences company called Emergent BioSolutions. The company is making a big bet on the NARCAN marketplace, selling one business and getting FDA approval for a new OTC product. An investment analysis around Emergent ...

Emergent has been delivering CYFENDUS™ vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use Authorization status, and will continue to work with the U.S. government to transition to post-approval procurement GAITHERSBURG, Md., July 20, 202...

2023-06-27 17:30:25 ET Contract healthcare manufacturing company Emergent BioSolutions (NYSE: EBS) was looking a bit under the weather as far as its stock was concerned on Tuesday. The company's share price plummeted by nearly 9% on the day following the news of a top-level executiv...

2023-06-27 13:38:04 ET Emergent BioSolutions ( NYSE: EBS ) said Tuesday that president and chief executive officer Robert G. Kramer Sr. will retire and step down from his positions effective immediately. The company has named Haywood Miller as interim...